http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2288619-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_907cd4295bf7676cb8e3a5d054b793c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbc4cee1147788fc0a2903793825bafb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-008
filingDate 2009-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e59b74c6ae7fb89b8f4d71df9ae7f80c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04fd12d0c640759bfbbe7ccfc08e38ee
publicationDate 2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2288619-B1
titleOfInvention Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals
abstract Non-native synthetic peptide cyclized by means of a disulphide bridge, characterized by the amino acid sequence (E34P) that follows (SEQ ID No.1): E-D-E-H-K-G-K-Y-C-R-L-G-N-D-C-R-T-T-E-P-T-T-T-A-T-P-R-G-T-P-T-P-A-P and complex of non-native synthetic peptides that is intended to induce and characterize the prevention and/or treatment of conditions in mammals, the protective immunity of which depends on the stimulation of Th1 lymphocytes, and in particular a delayed hyperstimulation state, containing: - said peptide (E34P), - the following sequence (A16E) of 16 amino acids (SEQ ID No.2) or derivatives (structural analogues) thereof: A-A-R-C-A-R-C-R-E-G-Y-S-L-T-D-E - the following sequence (A16G) of 16 amino acids (SEQ ID No.3) or derivatives (structural analogues) thereof: A-A-S-S-T-P-S-P-G-S-G-C-E-V-D-G -, and an adjuvant which preferably induces a cell-mediated response.
priorityDate 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11840927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128707670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128280294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451714

Total number of triples: 28.